CytoSite Bio

Business Services · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

14 Peterson Cir, Sudbury, Massachusetts,...

Phone Number

(978) 460-0695

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About CytoSite Bio

CytoSite Bio is pioneering advancements in immunotherapy by utilizing granzyme B to enhance cancer and autoimmune disease treatments. Their innovative platform includes a radiodiagnostic PET imaging solution that provides real-time insights into drug effectiveness and a preclinical radioimmunotherapy that has demonstrated a 100% response rate in animal models. Targeting researchers and healthcare professionals, CytoSite Bio aims to revolutionize clinical trial assessments and improve patient outcomes through their cutting-edge technologies. The company is focused on developing investigational products CSB-321 and CSB-421, which are not yet approved by regulatory authorities.Explore more
Popular SearchesCytoSite BioCytosite Biopharma IncCytosite BiopharmaSIC Code 87,873NAICS Code 54,541Show more

CytoSite Bio Org Chart

BL
United States flag for contact location.

Chief Executive Officer

PhoneEmail

Is CytoSite Bio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to CytoSite Bio

Compare insights from companies similar to CytoSite Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

CytoSite Bio

<$5M
1-10
Private
-
2016
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
<$5M
11-50
Private
$45.6M
2016
Niranjan Sardesai, Founder, President & Chief Executive Officer at Geneos Therapeutics
Niranjan SardesaiFounder, President & CEO
<$5M
1-10
Private
$142M
2012
Davis Ryman, Chief Medical Officer at Aeovian Pharmaceuticals
Davis RymanChief Medical Officer
<$5M
11-50
Private
-
2015
<$5M
1-10
Private
-
-
Michal Silverberg, Managing Director at Novartis Venture Fund
Michal SilverbergManaging Director
1-10
Public
$92M
2006
Matt Angel, President & Chief Executive Officer at Tempest Therapeutics
Matt AngelPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

CytoSite Bio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

CytoSite Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CytoSite Bio.

CytoSite Bio Tech Stack

A closer look at the technologies used by CytoSite Bio

Top Business Services Companies

Frequently Asked Questions Regarding CytoSite Bio

What is CytoSite Bio's official website?
CytoSite Bio's official website is www.cytositebio.com
What is CytoSite Bio's Revenue?
CytoSite Bio's revenue is <$5 Million
What is CytoSite Bio's SIC code?
CytoSite Bio's SIC: 87,873
What is CytoSite Bio's NAICS code?
CytoSite Bio's NAICS: 54,541
How many employees does CytoSite Bio have?
CytoSite Bio has 1-10 employees
What industry does CytoSite Bio belong to?
CytoSite Bio is in the industry of: Business Services, Research & Development
What is CytoSite Bio competition?
CytoSite Bio top competitors include: Tempest Therapeutics, Bolt Biotherapeutics, Revitope Oncology, Geneos Therapeutics
What technology does CytoSite Bio use?
Some of the popular technologies that CytoSite Bio uses are: WordPress.org, PHP, Cloudflare Website Optimization, Cloudflare CDN
How do I contact CytoSite Bio?
CytoSite Bio contact info: Phone number: (978) 460-0695 Website: www.cytositebio.com
What does CytoSite Bio do?

CytoSite Bio is pioneering advancements in immunotherapy by utilizing granzyme B to enhance cancer and autoimmune disease treatments. Their innovative platform includes a radiodiagnostic PET imaging solution that provides real-time insights into drug effectiveness and a preclinical radioimmunotherapy that has demonstrated a 100% response rate in an... imal models. Targeting researchers and healthcare professionals, CytoSite Bio aims to revolutionize clinical trial assessments and improve patient outcomes through their cutting-edge technologies. The company is focused on developing investigational products CSB-321 and CSB-421, which are not yet approved by regulatory authorities.Read More

Is CytoSite Bio a public company?
CytoSite Bio is private company therefore does not currently have an official ticker symbol
See more information about CytoSite Bio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.